The introduction of inhibitors of the cyclic GMP phosphodiesterase (PDE) 5 into clinical urology is mainly the result of the characterization of the physiology of nonvascular and vascular penile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback